Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters








Language
Year range
1.
Journal of Experimental Hematology ; (6): 282-285, 2008.
Article in Chinese | WPRIM | ID: wpr-253335

ABSTRACT

To explore the expression spectra of apoptosis-related gene pnas-2 in normal tissues and acute leukemia (AL) patient tissues, the expressions of pnas-2 gene in tissues including heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, lymph node, thymus, leukocyte, bone marrow and fetal liver were detected by Northern blot. The expressions of pnas-2 in samples including 44 de novo, 9 non-CR, 27 CR and 12 relapsed AL patients were measured by real-time RT-PCR and Northern blot, and the expression levels of pnas-2 in normal and tumor tissues from 31 patients with malignancies were also detected. The results showed that pnas-2 was not expressed in the most tissues except in placenta. The results of real-time PCR indicated that pnas-2 expressions in samples of de novo, non-CR and relapsed patients ware significantly higher than that in CR, tumor tissues and normal tissues. In serial monitoring of 7 AL patients, the expression level of pnas-2 was high at first visit examination, but remarkably decreased after remission, and the pnas-2 expression level increased again when relapsed. It is concluded that the pnas-2 is specifically up-regulated in acute leukemia patients, which might be an oncogene and participate in leukemogenesis.


Subject(s)
Humans , Acute Disease , Apoptosis , Genetics , Apoptosis Regulatory Proteins , Genetics , Metabolism , Biomarkers, Tumor , Genetics , Gene Expression Regulation, Leukemic , Leukemia , Pathology
2.
Chinese Journal of Oncology ; (12): 326-329, 2005.
Article in Chinese | WPRIM | ID: wpr-358640

ABSTRACT

<p><b>OBJECTIVE</b>Quercetin, a widely distributed natural flavonoid with a variety of biological functions, can reverse multidrug resistance (MDR) in leukemia according to recent researches. The aim of this study was to investigate the mechanisms of reversal of multi-drug resistance by quercetin mainly in respect of membrane transporters.</p><p><b>METHODS</b>MTT cell viability assay was used to verify the chemo-sensitization to daunorubicin (DNR) by quercetin in HL-60/ADM cell line and determine the effective reversal concentration, the expression of MRP(1) gene and its protein product, multidrug resistant associated protein 1 by RT-PCR and flow cytometry By confocal laser scanning microscopy, the subcellular distribution of DNR in HL-60/S and HL-60/ADM cells was examined before and after quercetin exposure.</p><p><b>RESULTS</b>Compared with HL-60/S, 20-40 micromol/L quercetin in vitro remarkably enhanced the sensitivity of HL-60/ADM cells to daunorubicin, down-regulated the expression of MRP(1) gene and its protein product MRP(1), restored the abnormal subcellular distribution of daunorubicin, so as to reverse MDR. Moreover, such an effective concentration of quercetin was non-toxic to the cells.</p><p><b>CONCLUSION</b>Quercetin could be a candidate of effective multidrug resistance-reversing agent with low toxicity in leukemia chemotherapy.</p>


Subject(s)
Humans , ATP Binding Cassette Transporter, Subfamily B , ATP Binding Cassette Transporter, Subfamily B, Member 1 , Antibiotics, Antineoplastic , Pharmacology , Daunorubicin , Pharmacology , Drug Resistance, Multiple , Drug Resistance, Neoplasm , HL-60 Cells , Quercetin , Pharmacology
3.
Chinese Journal of Oncology ; (12): 461-464, 2005.
Article in Chinese | WPRIM | ID: wpr-358603

ABSTRACT

<p><b>OBJECTIVE</b>To investigate if CYP3A5 gene is involved in the molecular mechanisms for multiple drug resistance in leukemia cells.</p><p><b>METHODS</b>A full length cDNA of CYP3A5 gene was cloned, and a recombinant eukaryotic expression plasmid was constructed, then stably transfected cell lines were established. Furthermore, the sensitivity of those cell lines to several anticancer drugs were assessed by MTT and FCM assay.</p><p><b>RESULTS</b>The recombinant plasmid was designated as pcDNA3-CYP3A5. Transfecting HL-60 cells (which didn't show transcript of CYP3A5 gene) with recombinant plasmid pcDNA3-CYP3A5 generated HL-60/CYP3A5 cell line, and transfecting of HL-60 cells with the parental pcDNA3 vector served as control HL-60/pc cell line. Daunorubicin induced remarkable apoptosis peaks in HL-60 and HL-60/pc cells, while such effect did not occur in HL-60/CYP3A5 cells (apoptosis cell percentage were 7.3%, 6.3% and 1.2%, respectively). Compared with HL-60 and HL-60/pc cells, HL-60/CYP3A5 cells were statistically significantly resistant to daunorubicin, aclacinomycin A, vincristine and harringtonine (resistance multiples were 2.89, 2.01, 4.05 and 2.79 times, respectively, P < 0.05), however the sensitivity to teniposide didn't change (resistance multiple was 1.04 times).</p><p><b>CONCLUSION</b>Transcription of CYP3A5 gene in leukemia cells directly induces resistance to anthracyclines and alkaloids, however the cells are still sensitive to epipodophyllotoxins. Therefore, our findings confirmed a new mechanism of multidrug resistance.</p>


Subject(s)
Humans , Aclarubicin , Pharmacology , Antibiotics, Antineoplastic , Pharmacology , Cytochrome P-450 CYP3A , Cytochrome P-450 Enzyme System , Genetics , Daunorubicin , Pharmacology , Drug Resistance, Multiple , Genetics , Drug Resistance, Neoplasm , Genetics , HL-60 Cells , Phenotype , Plasmids , Genetics , Recombination, Genetic , Transfection , Vincristine , Pharmacology
4.
Chinese Journal of Hematology ; (12): 171-174, 2004.
Article in Chinese | WPRIM | ID: wpr-291423

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the expression of VEGF mRNA and secretion of VEGF protein in NB4 and HL-60 cells affected by all-trans retinoic acid (ATRA) and daunorubincin (DNR) respectively.</p><p><b>METHODS</b>Semi-quantitative RT-PCR and ELISA were used to study the expression of VEGF mRNA and secretion of VEGF protein in NB4 and HL-60 cell lines treated by ATRA and DNR respectively.</p><p><b>RESULTS</b>VEGF was expressed in both NB4 and HL-60 cells. The expression of VEGF mRNA and secretion of VEGF protein could be down-regulated by ATRA and DNR respectively in a time and dose dependent manner.</p><p><b>CONCLUSION</b>Besides inducing apoptosis and restraining proliferation of leukemic cells, ATRA and DNR exerted their anti-leukemia effects by reducing angiogenesis via reduction of angiogenic reaction stimulating signals.</p>


Subject(s)
Humans , Apoptosis , Cell Line, Tumor , Cell Proliferation , Daunorubicin , Pharmacology , Gene Expression Regulation, Leukemic , HL-60 Cells , Leukemia , Drug Therapy , Genetics , Metabolism , Tretinoin , Pharmacology , Vascular Endothelial Growth Factors , Genetics , Metabolism
SELECTION OF CITATIONS
SEARCH DETAIL